Variant report

Variant	esv3369822
Chromosome Location	chr6:27007480-27037513
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:219)
CpG islands
(count:305)
Chromatin interactive
region (count:17)
LncRNA
region (count:10)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:219 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:27008143-27008217	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:27032893-27033093	K562	blood:	n/a	n/a
3	ATF1	chr6:27032966-27033254	K562	blood:	n/a	n/a
4	ATF2	chr6:27010947-27011512	GM12878	blood:	n/a	n/a
5	BACH1	chr6:27027985-27028100	K562	blood:	n/a	n/a
6	BACH1	chr6:27027903-27028160	H1-hESC	embryonic stem cell:	n/a	n/a
7	BATF	chr6:27011133-27011409	GM12878	blood:	n/a	n/a
8	BATF	chr6:27021502-27021814	GM12878	blood:	n/a	n/a
9	BATF	chr6:27020024-27020445	GM12878	blood:	n/a	n/a
10	BATF	chr6:27011083-27011441	GM12878	blood:	n/a	n/a
11	BATF	chr6:27020062-27020367	GM12878	blood:	n/a	n/a
12	BCL11A	chr6:27020059-27020386	GM12878	blood:	n/a	n/a
13	BHLHE40	chr6:27020277-27020288	GM12878	blood:	n/a	n/a
14	BHLHE40	chr6:27027748-27028068	HepG2	liver:	n/a	n/a
15	CBX3	chr6:27013755-27014076	K562	blood:	n/a	n/a
16	CEBPB	chr6:27034180-27034536	H1-hESC	embryonic stem cell:	n/a	chr6:27034220-27034231
17	CEBPB	chr6:27032859-27033287	K562	blood:	n/a	chr6:27032964-27032977
18	CEBPB	chr6:27008122-27008373	HepG2	liver:	n/a	n/a
19	CEBPB	chr6:27030088-27030295	A549	lung:	n/a	n/a
20	CEBPB	chr6:27029137-27029286	HepG2	liver:	n/a	n/a
21	CEBPB	chr6:27030000-27030295	HepG2	liver:	n/a	n/a
22	CEBPB	chr6:27015845-27015853	K562	blood:	n/a	n/a
23	CEBPB	chr6:27032928-27033250	K562	blood:	n/a	chr6:27032964-27032977
24	CEBPB	chr6:27034142-27034312	HepG2	liver:	n/a	chr6:27034220-27034231
25	CEBPB	chr6:27020259-27020446	HepG2	liver:	n/a	n/a
26	CEBPB	chr6:27008131-27008404	Hela-S3	cervix:	n/a	n/a
27	CHD2	chr6:27011150-27011332	GM12878	blood:	n/a	n/a
28	CHD2	chr6:27034380-27034513	HepG2	liver:	n/a	n/a
29	CTCF	chr6:27018240-27018390	HepG2	liver:	n/a	n/a
30	CTCF	chr6:27008060-27008210	HPAF	blood vessel:	n/a	n/a
31	CTCF	chr6:27008040-27008190	RPTEC	kidney:	n/a	n/a
32	CTCF	chr6:27008046-27008182	Hela-S3	cervix:	n/a	n/a
33	CTCF	chr6:27019200-27019245	GM13976	blood:	n/a	n/a
34	CTCF	chr6:27008060-27008210	Caco-2	colon:	n/a	n/a
35	CTCF	chr6:27007940-27008090	GM06990	blood:	n/a	n/a
36	CTCF	chr6:27015906-27016029	Spleen_OC	spleen:	n/a	n/a
37	CTCF	chr6:27008044-27008177	HepG2	liver:	n/a	n/a
38	CTCF	chr6:27018360-27018510	HEEpiC	esophagus:	n/a	n/a
39	CTCF	chr6:27008031-27008188	K562	blood:	n/a	n/a
40	CTCF	chr6:27008060-27008209	K562	blood:	n/a	n/a
41	CTCF	chr6:27016269-27016293	GM10248	blood:	n/a	n/a
42	CTCF	chr6:27008107-27008130	GM12878	blood:	n/a	n/a
43	CTCF	chr6:27019553-27019607	GM20000	blood:	n/a	n/a
44	CTCF	chr6:27008083-27008142	MCF-7	breast:	n/a	n/a
45	CTCF	chr6:27018260-27018410	WERI-Rb-1	eye:	n/a	n/a
46	CTCF	chr6:27018380-27018530	SAEC	small airway:	n/a	n/a
47	CTCF	chr6:27018414-27018509	H1-hESC	embryonic stem cell:	n/a	n/a
48	CTCF	chr6:27008020-27008170	HRE	kidney:	n/a	n/a
49	CTCF	chr6:27008000-27008150	GM12874	blood:	n/a	n/a
50	CTCF	chr6:27008100-27008141	GM19238	blood:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:27034685-27034735	GM12878	blood:	n/a
2	chr6:27013305-27013355	HNPCEpiC	eye:	n/a
3	chr6:27013341-27013391	MCF-7	breast:	n/a
4	chr6:27034685-27034735	HRPEpiC	eye:	n/a
5	chr6:27018112-27018162	PFSK-1	brain:	n/a
6	chr6:27013341-27013391	NHBE	bronchial:	n/a
7	chr6:27034685-27034735	HEEpiC	esophagus:	n/a
8	chr6:27013341-27013391	HepG2	liver:	n/a
9	chr6:27013341-27013391	HUVEC	blood vessel:	n/a
10	chr6:27013305-27013355	PANC-1	pancreas:	n/a
11	chr6:27013305-27013355	HCPEpiC	choroid plexus:	n/a
12	chr6:27018041-27018091	HepG2	liver:	n/a
13	chr6:27013305-27013355	GM12878	blood:	n/a
14	chr6:27018112-27018162	U87	brain:	n/a
15	chr6:27034685-27034735	HUVEC	blood vessel:	n/a
16	chr6:27018041-27018091	Jurkat	blood:	n/a
17	chr6:27018112-27018162	AG04449	skin:	fetal
18	chr6:27013341-27013391	NB4	blood:	n/a
19	chr6:27034685-27034735	Hela-S3	cervix:	n/a
20	chr6:27018041-27018091	RPTEC	kidney:	n/a
21	chr6:27018041-27018091	HRE	kidney:	n/a
22	chr6:27013305-27013355	ECC-1	luminal epithelium:	n/a
23	chr6:27034685-27034735	RPTEC	kidney:	n/a
24	chr6:27013341-27013391	NHDF-neo	bronchial:	n/a
25	chr6:27018041-27018091	HRPEpiC	eye:	n/a
26	chr6:27018112-27018162	ovcar-3	ovarian:	n/a
27	chr6:27018112-27018162	GM19239	blood:	n/a
28	chr6:27013305-27013355	HCM	heart:	n/a
29	chr6:27034685-27034735	ProgFib	skin:	n/a
30	chr6:27018041-27018091	NB4	blood:	n/a
31	chr6:27013305-27013355	HCF	heart:	n/a
32	chr6:27018041-27018091	HUVEC	blood vessel:	n/a
33	chr6:27018112-27018162	HRE	kidney:	n/a
34	chr6:27018041-27018091	A549	lung:	n/a
35	chr6:27018041-27018091	HEK293	kidney:	embryo
36	chr6:27018041-27018091	GM12891	blood:	n/a
37	chr6:27013305-27013355	AG09309	skin:	n/a
38	chr6:27034685-27034735	NHDF-neo	bronchial:	n/a
39	chr6:27018112-27018162	SK-N-SH	brain:	n/a
40	chr6:27018112-27018162	AG09319	gingival:	n/a
41	chr6:27018112-27018162	MCF-7	breast:	n/a
42	chr6:27013305-27013355	H1-hESC	embryonic stem cell:	embryo
43	chr6:27013305-27013355	HRPEpiC	eye:	n/a
44	chr6:27013341-27013391	ovcar-3	ovarian:	n/a
45	chr6:27013305-27013355	NT2-D1	testis:	n/a
46	chr6:27018112-27018162	Jurkat	blood:	n/a
47	chr6:27013341-27013391	HPAEpiC	pulmonary alveolar:	n/a
48	chr6:27034685-27034735	SK-N-SH_RA	brain:	n/a
49	chr6:27018112-27018162	NB4	blood:	n/a
50	chr6:27018112-27018162	NHBE	bronchial:	n/a

(count:17 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:27003462..27005530-chr6:27009729..27011589,3	K562	blood:
2	chr6:27012859..27015690-chr6:27113541..27115115,2	K562	blood:
3	chr6:27023374..27025084-chr6:27056380..27059252,2	K562	blood:
4	chr6:27020688..27023464-chr6:27032968..27035001,2	K562	blood:
5	chr6:26996900..26999485-chr6:27016466..27018181,2	K562	blood:
6	chr6:27036674..27038213-chr6:27040749..27042641,2	K562	blood:
7	chr6:26986603..26989305-chr6:27021996..27023724,2	K562	blood:
8	chr6:27026462..27028720-chr6:27031339..27033983,3	K562	blood:
9	chr6:27015857..27017940-chr6:27726768..27728788,2	K562	blood:
10	chr6:26922078..26923970-chr6:27032946..27034480,2	K562	blood:
11	chr6:27023604..27025976-chr6:27026786..27029380,4	K562	blood:
12	chr6:27020688..27023464-chr6:27032968..27035001,2	K562	blood:
13	chr6:26986639..26989482-chr6:27012858..27015749,2	K562	blood:
14	chr6:26121476..26124237-chr6:27029296..27031595,2	K562	blood:
15	chr6:26986842..26988770-chr6:27031968..27034490,2	K562	blood:
16	chr6:26987925..26989603-chr6:27006562..27008262,2	MCF-7	breast:
17	chr6:27026462..27028720-chr6:27031339..27033983,3	K562	blood:

(count:10 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HIST1H2AG-4	chr6:27032751-27032941	l_3147_NR_026775
2	lnc-HIST1H2BJ-2	chr6:27031382-27031615	NONHSAT108332
3	lnc-HIST1H2BJ-2	chr6:27037205-27037234	NONHSAT108332
4	lnc-HIST1H2BJ-6	chr6:27028144-27029028	NONHSAT108331
5	lnc-HIST1H2BJ-2	chr6:27037205-27037207	FPKM1_group_27392_transcript_1
6	lnc-HIST1H2BJ-2	chr6:27031383-27031615	XLOC_005657
7	lnc-HIST1H2AG-1	chr6:27012402-27012532	XLOC_005217
8	lnc-HIST1H2AG-1	chr6:27026475-27026687	XLOC_005217
9	lnc-HIST1H2BJ-2	chr6:27037206-27037234	XLOC_005657
10	lnc-HIST1H2BJ-2	chr6:27031382-27031615	FPKM1_group_27392_transcript_1

No data

Variant related genes	Relation type
VN1R13P	TF binding region
VN1R13P	CpG island
ENSG00000180596	chromatin interactions
ENSG00000197903	chromatin interactions
ENSG00000184825	chromatin interactions
ENSG00000216762	chromatin interactions
ENSG00000224843	chromatin interactions
ENSG00000238621	chromatin interactions
TCF7L1	miRNA target sites
TCF12	miRNA target sites

Extended variants
information (count: 990 )
Associated
traits (count: 105 )

Variant overlapped rSNPs/rCNVs (count:990 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs35598725	chr6:27007489-27007490	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs79900475	chr6:27007508-27007509	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs554232908	chr6:27007519-27007520	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs537209719	chr6:27007536-27007537	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs143987931	chr6:27007545-27007546	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs567349165	chr6:27007546-27007547	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs536009869	chr6:27007567-27007568	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs543877890	chr6:27007611-27007612	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs373352268	chr6:27007657-27007658	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs72838258	chr6:27007681-27007682	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs35741362	chr6:27007687-27007688	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs560770689	chr6:27007710-27007711	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs558949198	chr6:27007757-27007758	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs371308911	chr6:27007786-27007787	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs150937016	chr6:27007864-27007865	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs575566145	chr6:27007908-27007909	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs146889876	chr6:27007917-27007918	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs111401479	chr6:27007931-27007932	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs192817429	chr6:27007934-27007935	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs574589051	chr6:27007958-27007959	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs540321316	chr6:27007971-27007972	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs12193220	chr6:27008019-27008020	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs78361064	chr6:27008024-27008025	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs184263041	chr6:27008056-27008057	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs368431993	chr6:27008082-27008083	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs140595449	chr6:27008110-27008111	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs72838260	chr6:27008168-27008169	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs536494223	chr6:27008209-27008210	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs530858985	chr6:27008217-27008218	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs548589555	chr6:27008251-27008252	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs377077563	chr6:27008311-27008312	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs550783034	chr6:27008380-27008381	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs570335404	chr6:27008393-27008394	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs369723973	chr6:27008415-27008416	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs567510991	chr6:27008515-27008516	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs72838262	chr6:27008517-27008518	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs150463505	chr6:27008601-27008602	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs370271951	chr6:27008615-27008616	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs558542827	chr6:27008622-27008623	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs566586388	chr6:27008627-27008628	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs576950637	chr6:27008630-27008631	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs558166615	chr6:27008675-27008676	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs569200140	chr6:27008692-27008693	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs538194082	chr6:27008705-27008706	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs115434784	chr6:27008787-27008788	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs574894511	chr6:27008820-27008821	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs540837192	chr6:27008833-27008834	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs76889265	chr6:27008835-27008836	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs577294926	chr6:27008893-27008894	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs72838263	chr6:27008894-27008895	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:105)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21364760	CNVD
Williams Syndrome	20824207	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:137 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:26991800-27012000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr6:27003600-27008000	Weak transcription	K562	blood
3	chr6:27006000-27009200	Enhancers	HepG2	liver
4	chr6:27007000-27008200	Weak transcription	GM12878-XiMat	blood
5	chr6:27007800-27008000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr6:27008000-27008400	Enhancers	K562	blood
7	chr6:27008000-27008600	Enhancers	Hela-S3	cervix
8	chr6:27008200-27009000	Enhancers	GM12878-XiMat	blood
9	chr6:27009000-27010200	Weak transcription	GM12878-XiMat	blood
10	chr6:27009600-27015800	Weak transcription	Primary T helper naive cells from peripheral blood	blood
11	chr6:27010200-27011200	ZNF genes & repeats	GM12878-XiMat	blood
12	chr6:27011200-27012200	Enhancers	GM12878-XiMat	blood
13	chr6:27012000-27012800	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr6:27012800-27013600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr6:27013600-27014800	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
16	chr6:27014600-27014800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
17	chr6:27014600-27014800	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
18	chr6:27014600-27014800	Enhancers	Primary T helper cells fromperipheralblood	blood
19	chr6:27014600-27014800	Flanking Bivalent TSS/Enh	Gastric	stomach
20	chr6:27014600-27014800	ZNF genes & repeats	Pancreas	Pancrea
21	chr6:27014800-27016600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr6:27015600-27016400	Enhancers	Fetal Intestine Large	intestine
23	chr6:27016600-27018400	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
24	chr6:27017800-27018000	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
25	chr6:27017800-27018000	Flanking Bivalent TSS/Enh	Esophagus	oesophagus
26	chr6:27017800-27018200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
27	chr6:27017800-27018200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
28	chr6:27017800-27018200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
29	chr6:27017800-27018200	Enhancers	HMEC	breast
30	chr6:27017800-27018400	Enhancers	H1 Cell Line	embryonic stem cell
31	chr6:27017800-27018400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr6:27017800-27018400	Enhancers	Placenta	Placenta
33	chr6:27018000-27018200	Active TSS	iPS-15b Cell Line	embryonic stem cell
34	chr6:27018000-27018200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
35	chr6:27018000-27018200	ZNF genes & repeats	Right Atrium	heart
36	chr6:27018000-27018400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
37	chr6:27018000-27018400	Bivalent Enhancer	Esophagus	oesophagus
38	chr6:27018000-27018600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr6:27018200-27018400	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
40	chr6:27018200-27018600	Enhancers	HUES48 Cell Line	embryonic stem cell
41	chr6:27018200-27027800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
42	chr6:27018400-27018800	Enhancers	iPS-15b Cell Line	embryonic stem cell
43	chr6:27018600-27022000	Enhancers	HepG2	liver
44	chr6:27019000-27019800	Enhancers	GM12878-XiMat	blood
45	chr6:27019800-27020200	Flanking Active TSS	GM12878-XiMat	blood
46	chr6:27020200-27021400	Enhancers	GM12878-XiMat	blood
47	chr6:27021400-27021800	Flanking Active TSS	GM12878-XiMat	blood
48	chr6:27021600-27021800	Enhancers	Lung	lung
49	chr6:27021600-27022000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
50	chr6:27021800-27022600	Enhancers	GM12878-XiMat	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links